American Portfolios Advisors Edesa Biotech, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Mar 22, 2023
BUY
$4.2 - $11.92 $8 - $23
2 New
2 $15,000
Q2 2021

Mar 22, 2023
BUY
$4.93 - $6.69 $9 - $13
2 New
2 $11,000
Q1 2021

Mar 22, 2023
BUY
$4.3 - $7.48 $8 - $14
2 New
2 $11,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email